发明名称 |
Pharmaceutical Composition for the Treatment of Type 1-Diabetes |
摘要 |
A composition for the prevention or treatment of type I diabetes in a subject, said composition comprising a GABAergic and incretin exemplified by GABA and GLP-1/Ex4. These are optionally provided together in a single composition to promote beta-cell regeneration prevent beta-cell apoptosis and control autoimmunity for the prevention and treatment of T1D in mammals.
|
申请公布号 |
US2010166675(A1) |
申请公布日期 |
2010.07.01 |
申请号 |
US20090643008 |
申请日期 |
2009.12.21 |
申请人 |
|
发明人 |
WANG QINGHUA;NEPTON SOLTANI |
分类号 |
A61K9/12;A61K31/195;A61K31/7088;A61K38/17;A61K39/395;A61P3/10 |
主分类号 |
A61K9/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|